Best Supplements for Stress and Anxiety: Evidence Ranked

The question of which are the Best Supplements for Stress is no longer confined to wellness blogs — it is now a serious topic in clinical research. Chronic stress and anxiety affect millions of adults, and while lifestyle interventions remain first-line, many people want to know what the evidence actually says about nutritional and herbal options. This article ranks the supplements with the strongest human data, explains how they work, and flags where the science is still thin.

The Evidence Base

When evaluating supplements for stress and anxiety, the quality of evidence matters more than the number of studies. Randomized controlled trials (RCTs) in humans are the gold standard, followed by systematic reviews that pool multiple trials. Animal and in vitro studies can suggest mechanisms, but they do not prove efficacy in people.

Ashwagandha (Withania somnifera) stands out for having multiple RCTs in stressed and anxious adults. Chandrasekhar et al. (2012) conducted a prospective, randomized double-blind, placebo-controlled trial using a high-concentration full-spectrum root extract. Participants receiving ashwagandha showed significant reductions in stress-assessment scores and serum cortisol compared with placebo. The study used 300 mg twice daily for 60 days in adults with chronic stress.

Langade et al. (2019) extended this work to insomnia and anxiety, again using a randomized, double-blind, placebo-controlled design. The root extract improved sleep quality and reduced anxiety scores in adults with insomnia. These two RCTs are complemented by Pratte et al. (2014), who conducted a systematic review of human trial results for ashwagandha as an alternative treatment for anxiety. Their conclusion: the available evidence is promising, though larger and more rigorous trials are still needed.

Other ashwagandha studies support related but distinct outcomes. Wankhede et al. (2015) found improvements in muscle strength and recovery with ashwagandha supplementation, suggesting a broader adaptogenic profile. Choudhary et al. (2017) reported improved memory and cognitive functions in adults taking ashwagandha root extract. While these are not primary stress-anxiety trials, they hint at mechanisms — reduced stress may partly explain the cognitive and physical benefits.

Compared with ashwagandha, many other "stress supplements" lack this depth of human RCT data. Magnesium glycinate has mechanistic plausibility and some observational support, but the RCT literature for anxiety specifically is smaller. For a deeper look at that evidence, see our article on Magnesium and Anxiety.

Supplement	Key Study	Design	Dose & Duration	Outcome Strength
Ashwagandha (full-spectrum root extract)	Chandrasekhar et al. (2012)	RCT, double-blind, placebo-controlled	300 mg × 2 daily, 60 days	High
Ashwagandha (root extract)	Langade et al. (2019)	RCT, double-blind, placebo-controlled	300 mg × 2 daily, 10 weeks	Moderate–High
Ashwagandha	Pratte et al. (2014)	Systematic review of human trials	Varied	Moderate (promising, needs more data)
Magnesium glycinate	Multiple small RCTs	RCTs, mixed quality	200–400 mg elemental Mg daily	Low–Moderate
L-theanine	Small human trials	RCTs, limited size	200–400 mg daily	Low–Moderate

The Mechanism

Stress is not a single biochemical event. It involves the hypothalamic-pituitary-adrenal (HPA) axis, sympathetic nervous system activation, and downstream effects on inflammation, neuroplasticity, and sleep architecture. Effective supplements typically modulate one or more of these pathways.

Ashwagandha's primary bioactive compounds are withanolides, a class of steroidal lactones. These compounds appear to modulate the HPA axis and reduce circulating cortisol levels. In Chandrasekhar et al. (2012), ashwagandha supplementation was associated with a significant reduction in serum cortisol, suggesting a direct dampening effect on the hormonal stress response. This is consistent with the classical definition of an adaptogen: a substance that helps the body maintain homeostasis under stress.

Beyond HPA modulation, withanolides interact with GABA receptor signaling in animal models. GABA is the brain's main inhibitory neurotransmitter, and enhanced GABAergic tone is associated with reduced anxiety and improved sleep. Langade et al. (2019) observed both reduced anxiety scores and improved sleep parameters, which aligns with a GABA-related mechanism, though human receptor-binding data is limited.

Magnesium operates through a different but complementary pathway. As an NMDA receptor antagonist and natural calcium channel blocker, magnesium can reduce neuronal excitability. It also plays a role in regulating the HPA axis and limiting glutamate-driven excitotoxicity during chronic stress. Magnesium glycinate is often preferred for stress applications because the glycine amino acid itself has calming properties and the form is well-tolerated gastrointestinal

For a broader overview of how supplements interact with cortisol, adrenaline, and the stress response, see our Stress Hormones Supplement Guide.

What the Evidence Does — and Doesn't — Show

The ashwagandha literature has real strengths: multiple RCTs, placebo-controlled designs, and consistent direction of effect across studies. Chandrasekhar et al. (2012) and Langade et al. (2019) both used rigorous double-blind methods and reported statistically significant improvements. Pratte et al. (2014) systematically reviewed the human trial landscape and found the results encouraging.

However, there are important limitations. The total number of large, long-term RCTs remains small. Most trials have been 6–10 weeks in duration, so the safety and efficacy of year-long ashwagandha use are not well established. Study populations have often been adults with self-reported stress or insomnia, not clinically diagnosed anxiety disorders. Whether the effects generalize to people with generalized anxiety disorder (GAD) or panic disorder is unclear.

Wankhede et al. (2015) and Choudhary et al. (2017) add useful mechanistic context — ashwagandha may improve recovery and cognition — but these are not direct stress-reduction trials. They should not be cited as primary evidence for anxiety efficacy, only as supporting data for the herb's broader adaptogenic profile.

Another gap: head-to-head trials comparing ashwagandha with magnesium, L-theanine, or pharmaceutical interventions are essentially absent. We do not know which supplement is "best" in absolute terms, only that ashwagandha currently has the deepest human evidence base among herbal options.

Dosing, Forms, and Practical Nuances

Not all ashwagandha products are equivalent. The RCTs cited here used specific extracts, most notably KSM-66, a full-spectrum root extract standardized to 5% withanolides. This matters because leaf-only extracts or unstandardized powders may have different withanolide profiles and, potentially, different effects.

The doses used in positive RCTs typically range from 300 mg to 600 mg of extract per day, divided into one or two doses. Chandrasekhar et al. (2012) used 300 mg twice daily. Langade et al. (2019) used a similar dosing schedule. Taking ashwagandha with food may reduce mild gastrointestinal discomfort, which has been reported in a minority of participants.

For those considering a standardized full-spectrum root extract, Bio:sudo KSM-66 Reishi Restore combines KSM-66 ashwagandha with reishi mushroom, another adaptogen with a long history of traditional use. The reishi component has less RCT data for stress specifically, but the combination may appeal to people who want a multi-adaptogen formula built around the most studied ashwagandha extract.

Magnesium glycinate dosing is typically 200–400 mg of elemental magnesium daily, though many people start lower to assess tolerance. Unlike ashwagandha, magnesium does not have the same robust RCT evidence for anxiety reduction, but its mechanistic rationale and safety profile make it a common adjunct.

Who Benefits Most

The evidence is strongest for adults experiencing chronic stress or mild-to-moderate anxiety, particularly those with sleep disruption. Langade et al. (2019) specifically studied adults with insomnia and anxiety, and both outcomes improved. If your stress manifests as poor sleep, racing thoughts at night, or difficulty unwinding, ashwagandha has direct trial support.

People with physically demanding lifestyles may also benefit. Wankhede et al. (2015) showed improved muscle strength and recovery in resistance-trained men taking ashwagandha. For athletes or active individuals whose stress load includes both psychological and physical components, this dual benefit is relevant.

Cognitive support is another plausible use case. Choudhary et al. (2017) reported improved memory and executive function in adults taking ashwagandha. While this trial was not stress-specific, chronic stress is well known to impair cognition. If stress is degrading your focus or mental clarity, the cognitive data provides a secondary rationale.

Who should be cautious? Pregnant or breastfeeding women were excluded from these trials, so safety data is lacking. People with autoimmune conditions, thyroid disorders, or those taking sedative medications should consult a clinician before using ashwagandha, as withanolides can modulate immune and thyroid pathways in preclinical models. For a more detailed risk-benefit breakdown, see our Ashwagandha Anxiety Review.

Practical Takeaways

• Ashwagandha has the strongest human evidence among herbal supplements for stress and anxiety, with multiple RCTs showing reduced cortisol and improved symptom scores.
• Look for standardized root extracts (e.g., KSM-66 at 5% withanolides) rather than unstandardized powders or leaf-only products, since the positive trials used specific extract types.
• Typical effective doses are 300–600 mg daily of a concentrated root extract, usually divided into two doses. Effects are generally seen within 4–8 weeks.
• Magnesium glycinate is a reasonable adjunct with complementary mechanisms, though its direct RCT evidence for anxiety is thinner than ashwagandha's.
• Do not expect pharmaceutical-level effects. The magnitude of improvement in RCTs is meaningful but modest — supplements are adjuncts, not replacements for therapy or medication when those are indicated.
• Safety data beyond 10 weeks is limited. If you plan to use ashwagandha long term, periodic reassessment with a healthcare provider is prudent.

Bottom Line

If you are looking for the supplement with the most robust human evidence for stress and anxiety, ashwagandha — specifically standardized full-spectrum root extracts like KSM-66 — is the current leader. The RCTs by Chandrasekhar et al. (2012) and Langade et al. (2019) provide genuine, placebo-controlled evidence that it reduces stress markers and improves sleep. That said, the literature is still young, long-term safety data is limited, and supplements should be viewed as one tool in a broader stress-management strategy rather than a standalone solution.

References

1. Chandrasekhar K, et al. "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults." Indian Journal of Psychological Medicine. 2012;34(3):255–262. [Source]
2. Langade D, et al. "Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety." Medicine. 2019;98(37):e17186. [Source]
3. Wankhede S, et al. "Examining the effect of Withania somnifera supplementation on muscle strength and recovery." Journal of the International Society of Sports Nutrition. 2015;12:43. [Source]
4. Choudhary D, et al. "Efficacy and safety of ashwagandha (Withania somnifera) root extract in improving memory and cognitive functions." Journal of Dietary Supplements. 2017;14(6):599–612. [Source]
5. Pratte MA, et al. "An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha." Journal of Alternative and Complementary Medicine. 2014;20(12):901–908. [Source]

---

---